These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 1560154)

  • 21. Unusual plaque in a patient with recessive dystrophic epidermolysis bullosa.
    Zhu CS; Davis TL; Browning JC
    Pediatr Dermatol; 2021 Jul; 38(4):945-946. PubMed ID: 34448231
    [No Abstract]   [Full Text] [Related]  

  • 22. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
    Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous manifestation of squamous cell carcinoma in identical twins with epidermolysis bullosa.
    Hosokawa K; Yoshitatsu S; Kakibuchi M; Nishimoto S; Higashiyama M; Yoshikawa K
    Plast Reconstr Surg; 1998 Aug; 102(2):448-9. PubMed ID: 9703083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.
    Csikós M; Orosz Z; Bottlik G; Szöcs H; Szalai Z; Rozgonyi Z; Hársing J; Török E; Bruckner-Tuderman L; Horváth A; Kárpáti S
    Clin Exp Dermatol; 2003 Mar; 28(2):163-6. PubMed ID: 12653705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
    Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
    Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
    [No Abstract]   [Full Text] [Related]  

  • 26. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
    Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
    Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
    Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
    J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
    Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
    Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma in recessive dystrophic epidermolysis bullosa, presenting as an ulcer that appears to be filled with granulation tissue.
    Kalisiak MS; Edwards D; Lin AN
    J Cutan Med Surg; 2003; 7(3):229-31. PubMed ID: 12704532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rare case of recessive dystrophic epidermolysis bullosa and verruciform xanthoma.
    Orpin SD; Scott IC; Rajaratnam R; Colloby PS; Heagerty A
    Clin Exp Dermatol; 2009 Jan; 34(1):49-51. PubMed ID: 18681870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and Outcome of Squamous Cell Carcinoma in Epidermolysis Bullosa in Australia and New Zealand.
    Kim M; Li M; Intong-Wheeler LRA; Tran K; Marucci D; Murrell DF
    Acta Derm Venereol; 2018 Jan; 98(1):70-76. PubMed ID: 28853495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verruciform xanthoma developing in recessive dystrophic epidermolysis bullosa: A sheep in wolf's clothing.
    Curto-Barredo L; Segura S; Barranco C; Bellosillo B; Lloreta J; Toll A; Sanmartín O; Pujol RM
    Am J Dermatopathol; 2014 Jun; 36(6):506-9. PubMed ID: 23676320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of cutaneous pinch grafts in the healing of patients with dystrophic epidermolysis bullosa wounds: report of four cases].
    Claude O; Binder JP; Bustamante K; Blanchet-Bardon C; Andrivon F; Revol M; Servant JM
    Ann Chir Plast Esthet; 2005 Jun; 50(3):189-96. PubMed ID: 15963838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.
    Medek K; Koelblinger P; Koller J; Diem A; Ude-Schoder K; Bauer JW; Laimer M
    J Dtsch Dermatol Ges; 2019 Apr; 17(4):448-450. PubMed ID: 30821421
    [No Abstract]   [Full Text] [Related]  

  • 37. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
    Atanasova VS; Pourreyron C; Farshchian M; Lawler M; Brown CA; Watt SA; Wright S; Warkala M; Guttmann-Gruber C; Hofbauer JP; Fuentes I; Prisco M; Rashidghamat E; Has C; Salas-Alanis JC; Palisson F; Hovnanian A; McGrath JA; Mellerio JE; Bauer JW; South AP
    Clin Cancer Res; 2019 Jun; 25(11):3384-3391. PubMed ID: 30846478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
    Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
    Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
    Bonamonte D; Filoni A; De Marco A; Lospalluti L; Nacchiero E; Ronghi V; Colagrande A; Giudice G; Cazzato G
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.